Beijing Beilu Pharmaceutical Co., Ltd.

Beijing Beilu Pharmaceutical researches, develops, produces, and sells pharmaceutical products in China. It provides contrast agents, such as Iohexol injection, Gadolinol injection, Gadopentetate Dimeglumine injection, Iodixanol injection, and Iopamidol injection.

Its portfolio also includes Jiuweizhenxin granule, a central nervous system product, and oral anti-diabetic drugs, including Glimepiride tablets and Repaglinide tablets. Founded in 1992, the company is based in Beijing, China.